QuantuMDx Scales Up to Mass Manufacture Q-POC
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read MorePosted by Melanie Hamilton-Basich | Jan 12, 2021 | Covid 19, Flu & Respiratory Infections, POC Rapid Assays |
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read MorePosted by Laurie Bonner | Jan 8, 2021 | Covid 19, POC Reagents & Test Kits |
The self-administered, noninvasive saliva kits are FDA authorized for use by both individuals with and without symptoms of covid-19.
Read MorePosted by Laurie Bonner | Jan 4, 2021 | Covid 19 |
The online infographic provides a visualization of data about the coronavirus (covid-19) diagnostic tests authorized by the FDA in 2020.
Read MorePosted by Laurie Bonner | Dec 23, 2020 | Covid 19, POC Rapid Assays |
The easy-to-use, visually read test could expand testing for covid-19 to diverse point-of-care locations.
Read MorePosted by Melanie Hamilton-Basich | Dec 22, 2020 | Covid 19 |
HHS plans to provide weekly shipments of SARS-CoV-2 sample collection supplies to states and territories through at least March 2021.
Read More